NO995289D0 - Benzimidazol-derivater - Google Patents

Benzimidazol-derivater

Info

Publication number
NO995289D0
NO995289D0 NO995289A NO995289A NO995289D0 NO 995289 D0 NO995289 D0 NO 995289D0 NO 995289 A NO995289 A NO 995289A NO 995289 A NO995289 A NO 995289A NO 995289 D0 NO995289 D0 NO 995289D0
Authority
NO
Norway
Prior art keywords
group
substituted
optionally
alkyl group
alkylene
Prior art date
Application number
NO995289A
Other languages
English (en)
Other versions
NO995289L (no
Inventor
Keizo Tanikawa
Yoshimasa Kamikawaji
Mitsuaki Hirotsuka
Takehisa Iwama
Akiko Yamamoto
Yoichiro Fujita
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of NO995289L publication Critical patent/NO995289L/no
Publication of NO995289D0 publication Critical patent/NO995289D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
NO995289A 1997-05-01 1999-10-29 Benzimidazol-derivater NO995289D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11372397 1997-05-01
JP5530398 1998-03-06
PCT/JP1998/001986 WO1998050368A1 (en) 1997-05-01 1998-04-30 Benzimidazole derivative

Publications (2)

Publication Number Publication Date
NO995289L NO995289L (no) 1999-10-29
NO995289D0 true NO995289D0 (no) 1999-10-29

Family

ID=26396198

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995289A NO995289D0 (no) 1997-05-01 1999-10-29 Benzimidazol-derivater

Country Status (15)

Country Link
US (1) US6114369A (no)
EP (1) EP0980359B1 (no)
KR (1) KR100530208B1 (no)
CN (1) CN1095836C (no)
AT (1) ATE269851T1 (no)
AU (1) AU730650B2 (no)
CA (1) CA2285535C (no)
DE (1) DE69824722T2 (no)
HU (1) HUP0001010A3 (no)
IL (1) IL132575A0 (no)
NO (1) NO995289D0 (no)
NZ (1) NZ337749A (no)
RU (1) RU2188822C2 (no)
SK (1) SK146699A3 (no)
WO (1) WO1998050368A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4212466B2 (ja) * 2001-05-28 2009-01-21 イハラケミカル工業株式会社 アラルキルアミン誘導体の製造方法
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
US7419996B2 (en) * 2003-08-13 2008-09-02 The University Of Houston Parenteral and oral formulations of benzimidazoles
US7291744B2 (en) * 2003-11-13 2007-11-06 Bristol-Myers Squibb Company N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
EP2405905B1 (en) 2009-03-09 2016-06-29 SPI Pharma, INC. Highly compactable and durable direct compression excipients and excipient systems
CN103121970B (zh) * 2012-12-04 2015-04-29 中国科学院昆明植物研究所 苯并咪唑及其衍生物,其药物组合物及其在制备抗抑郁药物中的应用
CN103121969A (zh) * 2012-12-04 2013-05-29 中国科学院昆明植物研究所 苯并咪唑及其衍生物,其药物组合物及其应用
RU2711098C1 (ru) * 2019-04-15 2020-01-15 Федеральное государственное бюджетное научное учреждение "Федеральный Ростовский аграрный научный центр" (ФГБНУ ФРАНЦ) Производные нитропиридина, обладающие антибактериальной и протистоцидной активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244500B1 (no) * 1973-07-03 1977-07-01 Delalande Sa
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
US5290801A (en) * 1992-05-29 1994-03-01 The Du Pont Merck Pharmaceutical Company Benzimidazoles for the treatment of atherosclerosis
JPH09124609A (ja) * 1995-11-07 1997-05-13 Nissan Chem Ind Ltd ベンズイミダゾール誘導体

Also Published As

Publication number Publication date
HUP0001010A2 (hu) 2001-04-28
NO995289L (no) 1999-10-29
AU730650B2 (en) 2001-03-08
WO1998050368A1 (en) 1998-11-12
IL132575A0 (en) 2001-03-19
KR100530208B1 (ko) 2005-11-22
CN1253549A (zh) 2000-05-17
DE69824722D1 (de) 2004-07-29
HUP0001010A3 (en) 2001-06-28
SK146699A3 (en) 2000-05-16
KR20010020281A (ko) 2001-03-15
ATE269851T1 (de) 2004-07-15
AU7083098A (en) 1998-11-27
DE69824722T2 (de) 2004-12-09
CA2285535C (en) 2006-08-15
US6114369A (en) 2000-09-05
CA2285535A1 (en) 1998-11-12
NZ337749A (en) 2000-09-29
EP0980359A1 (en) 2000-02-23
CN1095836C (zh) 2002-12-11
EP0980359B1 (en) 2004-06-23
RU2188822C2 (ru) 2002-09-10

Similar Documents

Publication Publication Date Title
PE20040512A1 (es) Compuesto de pirazol-pirimidina anilina
CO5050332A1 (es) Composiciones fungicidas que comprenden 2-metoxibenzofenonas
GR3034398T3 (en) 2-[1',2',4'-triazol-3'-yloxymethylene]-anilides and their use as pest-control agents
ES8401031A1 (es) Una tetrahidroftalimida.
DE69317439D1 (de) Azoxycyanbenzol-Derivate
NO995289D0 (no) Benzimidazol-derivater
ATE71619T1 (de) Pyridazinon-derivate.
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
ATE167855T1 (de) Propensäure derivate verwendbar als fungizide
NO961404L (no) 4-indolylpiperazinyl-derivater
DK0847384T3 (da) Carbamoylcarboxylsyreamider
ES2055651A1 (es) Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles.
DE69228877D1 (de) Benzoaxole,benzothiazol und benzimidazol derivate als fungizide
ATE172724T1 (de) Anthelmintische benzimidazole
PT1140926E (pt) Azadiocicloalquenos e a sua utilizacao para combate contra fungos patogenicos e parasitas animais
ES2182775T3 (es) Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion.
ATE262522T1 (de) Benzimidazolverbindungen
DE69903930D1 (de) N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen
RO82994B1 (ro) Compozitie erbicida cu antidot
SE9901237D0 (sv) Novel use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application